Lung Cancers Completed Phase 2 Trials for Sunitinib (DB01268)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01829217Sunitinib in Never-Smokers With Lung AdenocarcinomaTreatment
NCT00620347Sunitinib as a Second-line Treatment for Patients With Recurrent Small Cell Lung CancerTreatment
NCT00430261Phase II Trial of Sunitinib in BAC or Never-Smokers With Any Lung AdenocarcinomaTreatment